OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Conditions
- Interventions
- First Posted Date
- 2008-11-25
- Last Posted Date
- 2016-02-29
- Target Recruit Count
- 850
- Registration Number
- NCT00797966
- Locations
- 🇺🇸
Florida Clinical Research Center, LLC, Bradenton, Florida, United States
🇺🇸Vince & Associates Clinical Research, Overland Park, Kansas, United States
🇺🇸Synergy Clinical Research Center, National City, California, United States
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2014-11-26
- Target Recruit Count
- 1081
- Registration Number
- NCT00731549
- Locations
- 🇺🇸
Study Site, San Diego, California, United States
Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 690
- Registration Number
- NCT00712686
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
- First Posted Date
- 2008-06-27
- Last Posted Date
- 2013-08-14
- Target Recruit Count
- 937
- Registration Number
- NCT00706654
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
- First Posted Date
- 2008-06-26
- Last Posted Date
- 2013-07-19
- Target Recruit Count
- 843
- Registration Number
- NCT00705783
- Locations
- 🇨🇳
Otsuka Investigational Site, Taipei, Taiwan
A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2021-12-01
- Target Recruit Count
- 481
- Registration Number
- NCT00685360
- Locations
- 🇵🇪
Hospital Nacional Sergio E. Bernales, Lima, Peru
🇵🇪Hospital Nacional Hipolito Unanue, Unanue, Peru
🇵🇪Hospital Nacional Daniel Alcides Carrión, Carrion, Peru
Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder
- Conditions
- Interventions
- First Posted Date
- 2008-04-23
- Last Posted Date
- 2013-12-02
- Target Recruit Count
- 493
- Registration Number
- NCT00665366
- Locations
- 🇹🇷
Local Institution, Denizli, Turkey
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
- First Posted Date
- 2007-10-29
- Last Posted Date
- 2011-04-28
- Target Recruit Count
- 57
- Registration Number
- NCT00550459
- Locations
- 🇺🇸
Lillestol Research, LLC, Fargo, North Dakota, United States
🇺🇸Otis Barnum, DO, Natchitoches, Louisiana, United States
🇺🇸Carolina Research Associates, Columbia, South Carolina, United States
Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Conditions
- Interventions
- First Posted Date
- 2007-01-30
- Last Posted Date
- 2017-07-02
- Target Recruit Count
- 1445
- Registration Number
- NCT00428948
- Locations
- 🇺🇸
Apex Research of Riverside, Riverside, California, United States
🇺🇸Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸University Hospitals of Cleveland/Case, Cleveland, Ohio, United States
Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- First Posted Date
- 2006-12-20
- Last Posted Date
- 2017-07-02
- Target Recruit Count
- 46
- Registration Number
- NCT00413777
- Locations
- 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
🇺🇸Jacksonville Center for Clinical Research, Jacksonville, Florida, United States
🇺🇸Emory University School of Medicine, Atlanta, Georgia, United States